Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 03 - 08 symbols : Snynf save search
Myelodysplastic Syndrome Market to Climb Swiftly at a 13.2% CAGR During the Study Period [2018-2030], Evaluates DelveInsight
Published: 2022-03-08 (Crawled : 16:00) - prnewswire.com
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: -0.38%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 3.03%
H: 0.0%
C: 0.0%
GERN | $3.495 -6.3% -6.72% 10M
|
Health Technology
|
| O: -0.97%
H: 5.88%
C: 1.96%
syndros
Icertis Announces Year of Record Growth
Published: 2022-03-08 (Crawled : 16:00) - prnewswire.com
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 3.03%
H: 0.0%
C: 0.0%
ces growth
Going All In on mRNA, Sanofi Breaks Ground on New Vaccine Site
Published: 2022-03-08 (Crawled : 15:00) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 3.03%
H: 0.0%
C: 0.0%
new vaccine vaccine
Sanofi recognized by S&P as one of the most sustainability-committed companies
Published: 2022-03-08 (Crawled : 13:30) - globenewswire.com
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 3.03%
H: 0.0%
C: 0.0%
one
BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC
Published: 2022-03-08 (Crawled : 13:30) - globenewswire.com
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 3.03%
H: 0.0%
C: 0.0%
BNTX | News | $88.53 0.59% 0.59% 360K
|
Health Technology
|
| O: -7.15%
H: 7.89%
C: 3.44%
libtayo collaboration
Hematological Malignancies Drugs Market worth $ 42.78 Billion by 2030 - Exclusive Report by InsightAce Analytic
Published: 2022-03-08 (Crawled : 11:00) - prnewswire.com
GNMSF | News | $289.67 3.83% 5.3K
|
Health Technology
|
| O: -0.14%
H: 5.36%
C: 5.36%
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: -2.75%
H: 0.28%
C: -1.04%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: 0.0%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: 0.38%
H: 1.81%
C: 0.28%
BMY | $48.99 -0.31% 0.0% 9.1M
|
Health Technology
|
| O: -1.55%
H: 0.71%
C: -0.28%
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: 0.29%
H: 0.6%
C: -1.24%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 3.03%
H: 0.0%
C: 0.0%
GILD | $67.03 0.12% 0.12% 5.2M
|
Health Technology
|
| O: 1.4%
H: 0.7%
C: -1.15%
GMAB | News | $28.54 -1.48% -1.51% 560K
|
Health Technology
|
| O: -0.3%
H: 3.38%
C: 0.32%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 0.35%
H: 0.0%
C: 0.0%
ema drug report
Non-small Cell Lung Cancer Drugs Market to Grow by USD 30.23 billion| Increasing Prevalence and Incidence of Non-small Cell Lung Cancer to Boost Market Growth | Technavio
Published: 2022-03-08 (Crawled : 08:00) - prnewswire.com
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: -2.09%
H: 5.03%
C: 0.85%
ALPMY | News | $9.53 -1.11% 690K
|
Manufacturing
|
| O: 1.01%
H: 0.81%
C: -0.06%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -4.98%
H: 0.0%
C: 0.0%
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: 0.29%
H: 0.6%
C: -1.24%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 3.03%
H: 0.0%
C: 0.0%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: -0.44%
H: 0.0%
C: 0.0%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 0.35%
H: 0.0%
C: 0.0%
drug cel lung cancer cancer drug cancer growth
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.